**Summary**
THG PLC announced the disposal of Claremont Ingredients to Nactarome Group for £103 million in cash, marking a significant return on investment since its acquisition in 2020 for £52 million. This move aligns with THGs strategy to simplify its portfolio and reduce net leverage. Claremont, a UK-based flavour manufacturing specialist, enhanced Myproteins product development capabilities, and its relationship with THG will be maintained through a long-term supply contract.
**Financial Highlights**
**H1 2025** Adjusted EBITDA of £24 million (down from £37.1 million in H1 2024) due to higher whey pricing. Cash and available facilities at £278 million, with net debt at £330 million (proforma £230 million post-disposal).
**H2 2025 Outlook** THG Nutrition expects 10-12% revenue growth, supported by stable whey prices and rising consumer prices. Myprotein will limit price increases to prioritize market share growth, with a £15 million investment in 2025, resulting in a Group adjusted EBITDA of £50 million for H2.
**FY 2026** Group EBITDA expected to adjust solely for Claremonts disposal, with a focus on operating leverage and market share gains.
**Strategic Updates**
THG Nutrition delivered double-digit revenue growth in June and July, with a focus on expanding Myproteins global offline retail presence from 34,000 to 100,000 doors.
THG Beauty also saw improved revenue growth in H2.
**CEO Comment**
Matthew Moulding highlighted Claremonts success in building Myproteins global licensing franchise and emphasized the disposals strategic alignment with THGs focus on core strengths and a strong balance sheet.
**About THG PLC**
THG is a global e-commerce group operating THG Beauty (platforms like Lookfantastic, Dermstore, Cult Beauty) and THG Nutrition (led by Myprotein), with a focus on health, wellness, and beauty categories.